Showing results (131-140 of 140) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
The Journal of Physical Chemistry. B|November 22, 2012
Inhibitor-induced conformational shifts and ligand-exchange dynamics for HIV-1 protease measured by pulsed EPR and NMR spectroscopyXi Huang, Ian Mitchelle S de Vera, Angelo M Veloro, et al.The Journal of Biological Chemistry|April 19, 2014
The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamicsXi Huang, Manuel D Britto, Jamie L Kear-Scott, et al.FEBS Letters|July 2, 2014
Effects of PRE and POST therapy drug-pressure selected mutations on HIV-1 protease conformational samplingJeffrey D Carter, Estrella G Gonzales, Xi Huang, et al.The Journal of Biological Chemistry|September 1, 2016
Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure EvolutionZhanglong Liu, Xi Huang, Lingna Hu, et al.Physical Chemistry Chemical Physics : PCCP|October 23, 2015
Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shiftsZhanglong Liu, Thomas M Casey, Mandy E Blackburn, et al.Photodiagnosis and Photodynamic Therapy|December 12, 2024
Analysis of tumoral, stromal and glycolitic markers in the response basal cell carcinoma and Bowen disease to photodynamic therapy in real lifeL Bernal-Masferrer, T Gracia-Cazaña, L Najera-Botello, et al.Physical Review Letters|June 1, 2001
Magnetic spin ladder (C5H12N)2CuBr4: high-field magnetization and scaling near quantum criticalityB C Watson, V N Kotov, M W Meisel, et al.NPJ Breast Cancer|May 13, 2023
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trialKristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, et al.Plos One|August 30, 2014
Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cellsIván González-Chavarría, Rita P Cerro, Natalie P Parra, et al.ESMO Open|January 20, 2026
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancerF Lynce, C Valenza, S M Niman, et al.Pageof 14